253 related articles for article (PubMed ID: 33965770)
21. Snakebite in tropical Australia: a prospective study in the "Top End" of the Northern Territory.
Currie BJ
Med J Aust; 2004 Dec 6-20; 181(11-12):693-7. PubMed ID: 15588215
[TBL] [Abstract][Full Text] [Related]
22. Wound Infections of Snakebites from the Venomous
Lin CC; Chen YC; Goh ZNL; Seak CK; Seak JC; Shi-Ying G; Seak CJ; Spot Investigators
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32906845
[TBL] [Abstract][Full Text] [Related]
23. Study of snake bite cases at Liaquat University Hospital Hyderabad/Jamshoro.
Hayat AS; Khan AH; Shaikh TZ; Ghouri RA; Shaikh N
J Ayub Med Coll Abbottabad; 2008; 20(3):125-7. PubMed ID: 19610536
[TBL] [Abstract][Full Text] [Related]
24. Presentation and Management of Venomous Snakebites: Should All Patients Be Transferred to a Tertiary Referral Hospital?
Irion VH; Barnes J; Montgomery BE; Suva LJ; Montgomery CO
J Surg Orthop Adv; 2016; 25(2):69-73. PubMed ID: 27518288
[TBL] [Abstract][Full Text] [Related]
25. Pediatric sex group differences in location of snakebite injuries requiring antivenom therapy.
Matteucci MJ; Hannum JE; Riffenburgh RH; Clark RF
J Med Toxicol; 2007 Sep; 3(3):103-6. PubMed ID: 18072145
[TBL] [Abstract][Full Text] [Related]
26. Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population.
Gerardo CJ; Evans CS; Kuchibhatla M; Mando-Vandrick J; Drake WG; Yen M; Kopec K; Lavonas EJ
Acad Emerg Med; 2015 Mar; 22(3):308-14. PubMed ID: 25728451
[TBL] [Abstract][Full Text] [Related]
27. Management of Tissue Loss After Agkistrodon Snakebite: Appropriate Use of Crotalidae-Fab Antivenin.
Larson KW; Schaefer KR; Austin C; Norton R; Finley PJ
J Trauma Nurs; 2016; 23(3):169-72. PubMed ID: 27163225
[TBL] [Abstract][Full Text] [Related]
28. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation.
Offerman SR; Bush SP; Moynihan JA; Clark RF
Pediatrics; 2002 Nov; 110(5):968-71. PubMed ID: 12415038
[TBL] [Abstract][Full Text] [Related]
29. When It Comes to Snakebites, Kids Are Little Adults: a Comparison of Adults and Children with Rattlesnake Bites.
Levine M; Ruha AM; Wolk B; Caravati M; Brent J; Campleman S; Wax P;
J Med Toxicol; 2020 Oct; 16(4):444-451. PubMed ID: 32394223
[TBL] [Abstract][Full Text] [Related]
30. Use of antivenom for snakebites reported to United States poison centers.
Spiller HA; Bosse GM; Ryan ML
Am J Emerg Med; 2010 Sep; 28(7):780-5. PubMed ID: 20837254
[TBL] [Abstract][Full Text] [Related]
31. Clinico-Epidemiological Profile, Trends, and Health-Related Outcomes of Snakebite Victims: A One-Year Prospective Study from Eastern India.
Stephen S; Mohanty CR; Radhakrishnan RV; Issac A; Jacob J; Krishnan N; Vr V; Guru S; Muhammed Shaji I; Aggarwal A
Wilderness Environ Med; 2024 Jun; 35(2):155-165. PubMed ID: 38634117
[TBL] [Abstract][Full Text] [Related]
32. Snakebite treatment at a southeastern regional referral center.
Rudolph R; Neal GE; Williams JS; McMahan AP
Am Surg; 1995 Sep; 61(9):767-72. PubMed ID: 7661472
[TBL] [Abstract][Full Text] [Related]
33. Using geographical information systems to identify populations in need of improved accessibility to antivenom treatment for snakebite envenoming in Costa Rica.
Hansson E; Sasa M; Mattisson K; Robles A; Gutiérrez JM
PLoS Negl Trop Dis; 2013; 7(1):e2009. PubMed ID: 23383352
[TBL] [Abstract][Full Text] [Related]
34. An investigation of snakebite antivenom usage in Taiwan.
Lin CC; Chaou CH; Tseng CY
J Formos Med Assoc; 2016 Aug; 115(8):672-7. PubMed ID: 26250942
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of snakebite and use of antivenom in Argentina.
Dolab JA; de Roodt AR; de Titto EH; García SI; Funes R; Salomón OD; Chippaux JP
Trans R Soc Trop Med Hyg; 2014 May; 108(5):269-76. PubMed ID: 24619585
[TBL] [Abstract][Full Text] [Related]
36. Treatment of poisonous snakebites in northern Taiwan.
Chen JC; Liaw SJ; Bullard MJ; Chiu TF
J Formos Med Assoc; 2000 Feb; 99(2):135-9. PubMed ID: 10770028
[TBL] [Abstract][Full Text] [Related]
37. A prospective cohort study of the effectiveness of the primary hospital management of all snakebites in Kurunegala district of Sri Lanka.
Shahmy S; Kularatne SAM; Rathnayake SS; Dawson AH
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005847. PubMed ID: 28827807
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of antivenom therapy for Vipera palaestinae bites in children: experience of two large, tertiary care pediatric hospitals.
Pivko-Levy D; Munchnak I; Rimon A; Balla U; Scolnik D; Hoyte C; Voliovitch Y; Glatstein M
Clin Toxicol (Phila); 2017 Apr; 55(4):235-240. PubMed ID: 28103732
[TBL] [Abstract][Full Text] [Related]
39. Emergency Department Visits by Pediatric Patients for Snakebites.
Tadros A; Sharon M; Davis S; Quedado K; Marple E
Pediatr Emerg Care; 2022 Jun; 38(6):279-282. PubMed ID: 35507370
[TBL] [Abstract][Full Text] [Related]
40. Clinical effects and antivenom use for snake bite victims treated at three US hospitals in Afghanistan.
Heiner JD; Bebarta VS; Varney SM; Bothwell JD; Cronin AJ
Wilderness Environ Med; 2013 Dec; 24(4):412-6. PubMed ID: 23870762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
